Published in Medical Patent Week, January 7th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Virginia Commonwealth University, U.S.
Report 1: Virginia Commonwealth University researchers have developed a unique anti-sickling agent that may one day be effective in treating sickle cell disease, a painful and debilitating genetic blood disorder that affects approximately 80,000 Americans.
The research team led by Donald Abraham, PhD, the Alfred and Frances Burger Professor of Biological and Medicinal Chemistry, in the Department of Medicinal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Week